Three Bridge Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.19M Buy
57,590
+21,719
+61% +$1.03M 0.6% 25
2025
Q4
$1.83M Buy
35,871
+3,110
+9% +$159K 0.48% 32
2025
Q3
$1.82M Buy
32,761
+7,811
+31% +$457K 0.47% 32
2025
Q2
$1.72M Buy
24,950
+1,285
+5% +$87.4K 0.45% 35
2025
Q1
$1.67M Buy
23,665
+11,107
+88% +$917K 0.58% 31
2024
Q4
$1.08M Buy
12,558
+150
+1% +$16.2K 0.38% 40
2024
Q3
$1.48M Sell
12,408
-286
-2% -$38.1K 0.55% 36
2024
Q2
$1.81M Sell
12,694
-326
-3% -$43.2K 0.72% 30
2024
Q1
$1.68M Sell
13,020
-877
-6% -$104K 0.66% 31
2023
Q4
$1.44M Sell
13,897
-1,431
-9% -$142K 0.5% 29
2023
Q3
$1.39M Sell
15,328
-296
-2% -$26.1K 0.58% 30
2023
Q2
$1.26M Sell
15,624
-2,680
-15% -$219K 0.54% 33
2023
Q1
$1.47M Sell
18,304
-7,394
-29% -$524K 0.68% 30
2022
Q4
$1.74M Buy
25,698
+118
+0.5% +$6.92K 0.93% 22
2022
Q3
$1.27M Sell
25,580
-464
-2% -$24.9K 0.65% 33
2022
Q2
$1.45M Sell
26,044
-1,338
-5% -$74.2K 0.71% 31
2022
Q1
$1.53M Buy
+27,382
New +$1.41M 0.43% 29

Other funds holding NVO

Three Bridge Wealth Advisors's NVO Position: Q1 2026 in Review

Three Bridge Wealth Advisors increased its Novo Nordisk (NVO) stake by 61% in Q1 2026, buying an estimated $1.03M and bringing the position to 57,590 shares worth $2.19M. The position accounts for 0.6% of the portfolio, ranked #25.

Three Bridge Wealth Advisors first reported a position in NVO in Q1 2022 and has held it in 17 quarters since. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Three Bridge Wealth Advisors held 57,590 shares of Novo Nordisk worth $2.19M as of Q1 2026.
  • Three Bridge Wealth Advisors bought 21,719 Novo Nordisk shares in Q1 2026, an estimated $1.03M.
  • Novo Nordisk made up 0.6% of Three Bridge Wealth Advisors's portfolio in Q1 2026, its #25 holding.
  • Three Bridge Wealth Advisors first reported a position in Novo Nordisk in Q1 2022 and has held it in 17 quarters since.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Three Bridge Wealth Advisors's 13F filing for Q1 2026, filed 12 May 2026.